CompaniesActiGraph

ActiGraph

defunct
About

Defunct Company

Areas of Focus

Categories

Bankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (3)
View all

Total Trials

3

As Lead Sponsor

1

As Collaborator

2

Total Enrollment

293

By Phase

PHASE3: 1PHASE2: 1

By Status

TERMINATED: 2RECRUITING: 1
Clinical Trials Pipeline3 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
Today
NCT03714815
NCT03775421
NCT06448689
Hover over trial bars to see details

Recent Trials

NCT06448689Lead Sponsor
Analytical Validation of Wrist-Based Assessment of Nocturnal Scratch in Atopic Dermatitis and Psoriasis
N/ARecruiting
90 participants
Started: Mar 12, 2024 · Completed: Jun 30, 2026
NCT03775421Collaborator
An Upcoming Clinical Study to Measure the Safety and Impact of a Drug Called Macitentan in Teenage and Adult Fontan Patients.
PHASE3Terminated
112 participants
Started: Apr 11, 2019 · Completed: Jan 18, 2022
NCT03714815Collaborator
A Long Term Study to Find Out if Macitentan is an Effective and Safe Treatment for Patients With Heart Failure With Preserved Ejection Fraction and Pulmonary Vascular Disease
PHASE2Terminated
91 participants
Started: Dec 7, 2018 · Completed: Oct 12, 2021